PPBT stock news · Purple Biotech
Get alerts for PPBT
Follow Purple Biotech (PPBT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PPBTFree on the App Store and Google Play, or on the web.
Purple Biotech lost $1.0 million last quarter but plans to submit an application for its main drug in 2027.
NeutralPurple Biotech’s quarterly loss narrowed to $1.0 million from $1.3 million a year earlier, but it ended with $5.1 million in cash. The report leaves its outlook unchanged.